Search | Social.So

Rutuja Deshmukh added blog Other
2026-07-02 12:02:26 -

Rare Disease Genetic Testing Market Competitive Analysis and Key Players
The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

0 Comments 0 Shares 30 Views 0 Reviews

Please log in to like, share and comment!
Workin Dbmr added blog Networking
2026-06-26 04:09:00 -

How Is Genetic Risk Awareness Driving the North America Hereditary Cancer Testing Market?
According to the latest report published by Data Bridge Market Research, the North America Hereditary Cancer Testing Market CAGR Value The North America hereditary cancer testing market size was valued at USD 3.39 billion in 2025 and is expected to reach USD 9.20 billion by 2033, at a CAGR of 13.3% during the forecast period Market research analysis and data in this North...

0 Comments 0 Shares 49 Views 0 Reviews

Please log in to like, share and comment!
Stephen Grey added blog Other
2026-07-03 14:54:17 -

Molecular Cytogenetics Market Expands with Rising Demand for Genetic Testing
The Molecular Cytogenetics Market is experiencing significant growth as the demand for advanced genetic testing continues to rise across clinical diagnostics, cancer research, and personalized medicine. Molecular cytogenetics combines molecular biology with cytogenetic techniques to identify chromosomal abnormalities at a higher resolution, enabling accurate diagnosis of genetic...

0 Comments 0 Shares 9 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-03 07:23:31 -

qPCR Instruments Market Investment Opportunities and Forecast
The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

0 Comments 0 Shares 30 Views 0 Reviews

Please log in to like, share and comment!